|
Event Note · 7 August 2026
Imricor Medical Systems, Inc.
ASX:IMR · Health Care
Philips TAM Unlocked!
Philips issued a Third Party Product Compatibility Declaration covering Imricor Medical Systems, Inc. (ASX:IMR) 's capital equipment and consumables - for use with Philips MR systems. We estimate this unlocks 17-27% of US & EU TAM for IMR respectively. Our DCF Valuation for Imricor is A$3.1 which is ~60% above the current market price. Philips has issued a Third Party Product Compatibility Declaration covering Imricor's capital equipment and consumables.
Recommendation: We have a A$3.1 valuation for IMR which is ~60% above the current market price. Imricor will report their 1H26 results next Monday 10th August 2026, and host a webinar 08:45 AEST. Registration link. Fig 1: US MR split by vendor Source: Homodeus estimates Fig 2: EU MR split by vendor Source: Homodeus estimates Fig 3: Status by major vendor Source: Company data, Homodeus research |